Idexx Laboratories Inc (IDXX)
- Sector
- Health Care
- Industry
- Health Care Equipment
- Last price
- $529.01
- As of
Kresmion compiles this page from IDXX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
IDEXX LABORATORIES INC /DE (IDXX): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-04.
See the full IDXX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for IDXX on one page. Preview it with sample data, then open it live with a free account.
Preview the IDXX dossierActive signals for IDXX
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 66% of IDXX (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 54% of IDXX (2026Q2)
- highCONSENSUS_BUY
3 tracked funds increased IDXX this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 99% of IDXX (2026Q2)
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +103% to IDXX (2026Q2)
FREE, NO ACCOUNT
Every signal on IDXX, as it fires
You are seeing 5 of 29 signals recorded on IDXX since 2026-05-05.
The five above all landed on 2026-08-16. The other 24 were recorded on 4 other days. 24 of the 29 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in IDXX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP 45168D104 · 2026Q2 | $138.4M | 0.15% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 45168D104 · 2026Q2 | $57.8M | 0.08% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 45168D104 · 2026Q2 | $41.6M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 45168D104 · 2026Q2 | $20.5M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 45168D104 · 2026Q2 | $17.7M | 0.07% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 45168D104 · 2026Q2 | $537K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, IDXX
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
IDXX against its peers
IDXX's operating margin of 31.6% ranks in the 90th percentile of 14 Health Care Equipment sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-06-30.
| Metric | IDXX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 4.3B USD | 9.1B USD | 17 | 14 |
| Gross margin | 61.8% | 62.5% | 50 | 10 |
| Operating margin | 31.6% | 18.1% | 90 | 14 |
| Net margin | 24.6% | 13.2% | 83 | 14 |
| Return on equity | 66.0% | 12.2% | 97 | 14 |
| P / E | 40.4x | 27.7x | 75 | 13 |
| 1 year | -16.9% | -5.5% | 30 | 14 |
Peers (14): EW, RMD, DXCM, GEHC, BSX, STE, RVTY, ZBH, SYK, MDT, BAX, ISRG, PODD, ABT. Left out: BDX (no annual filing). Fiscal periods ending between 2025-12-28 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (IDXX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow IDXX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to IDXX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.